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The simplest model for the function of helper T  cells in the antibody response 
is that they act by recognizing antigen on the surface of antigen-specific B cells. 
This model accommodates the classic experiments of Mitchison (1), showing that 
T  cells and B cells must recognize portions of the same antigen molecule in order 
to collaborate (linked recognition). Also, since helper T  cells recognize antigen 
in the context of class II major histocompatibility complex (MHC) 1 antigens, this 
model  predicts  the  finding  that  T  cell-B  cell  collaboration  is  often  MHC- 
restricted (2-5), and that Ir genes, which influence T  cell recognition of antigen, 
are expressed in B cells (6). 
Since T-B collaboration occurs at antigen concentrations in the nanogram per 
milliliter range,  the model also requires  that the B  cell serve as a  particularly 
efficient antigen-presenting cell for those antigens which can bind its antigen 
receptor.  A  direct test of this prediction,  however,  is severely limited by  the 
clonal distribution  of antigen receptors.  Even with primed cell populations in 
vitro,  the  frequency  of antigen-specific,  MHC-restricted  T-B  collaboration  is 
exceedingly low, and the collaboration is not visible until the B cells begin to 
make antibody. 
The advent of long-term T cell lines has solved half of this problem. Polyclonal, 
MHC-restricted  B  cell  responses  can  be  induced  in  unprimed  B  cells  using 
alloreactive T  cell lines or clones (7, 8), or using protein antigen-specific T  cell 
clones and very high antigen concentrations,  which enable B  cells to take up 
antigen nonspecifically (9,  10). These experiments show directly that B cells can 
induce and receive help by acting as antigen-presenting cells. Since most, but not 
all (8,  11) of these experiments do not explicitly involve membrane Ig (mIg), 
they suggest that a signal delivered via mIg is not absolutely necessary for B cell 
activation  when  activation  is  a  consequence  of helper  T  cell  recognition  of 
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antigen on the B cell surface; a conclusion reached earlier by Cammisuli et al. 
(12) for primed B cells. However, since these experiments circumvent mIg, they 
cannot approach the question of how the antigen receptor on the B cell might 
function in antigen-specific responses to  enhance T-B collaboration.  Possible 
roles include passive antigen binding or "focusing" (13), as well as more active 
roles in antigen processing and presentation (14), or transmembrane signalling 
to enable the B cell to induce and receive a helper signal (15). 
In our previous studies on the role of mIg in B cell responses, we used anti-Ig 
as a polyclonal model for antigen, and T cell-derived, stable, antigen-nonspecific, 
soluble helper factors in place of T  cells. We, and others (15-20), have shown 
that high concentrations (>1  tzg/ml) of anti-Ig activate B lymphocytes, as mea- 
sured by an increase in RNA content per cell (16),  cell size (17,  18),  or DNA 
synthesis (15), and induce responsiveness to T  cell-derived helper factors that 
enable the cells to proliferate and secrete Ig (15, 19, 20). This model is based on 
the classical experiments of Dutton et al.  (21),  and Schimpl and Wecker (22), 
which showed that helper T  cell function in the in vitro response to heterologous 
erythrocytes can be replaced by soluble, antigen-nonspecific factors produced by 
activated T  cells. However, the response to erythrocytes and high concentrations 
of anfi-Ig may differ from the response to low concentrations of protein antigens. 
Helper T  cell  function for low concentrations of protein antigens cannot be 
replaced by the same factors (4,  5,  23),  nor are hapten-protein conjugates as 
effective as anti-Ig in activating isolated, hapten-specific B cells (24, 25). More- 
over, B cells from the CBA/N  mouse, which fails to respond to anti-Ig, or to 
antigen  and  helper  factors  under  certain  conditions,  can  still  be  induced  to 
respond by MHC-restricted helper T  cells (5,  26).  Consequently, helper T  cell 
recognition of antigen on the B cell surface appears to induce helper signals that 
are not provided by stable helper factors. 
To investigate the role of mIg in a polyclonal model of MHC-restricted T-B 
collaboration that involves these other signals, we have taken advantage of the 
recent finding (14, 27) that B cell blasts present 'rabbit anti-Ig very efficiently to 
mouse lymph node T  cells primed with normal rabbit Ig, as measured by T  cell 
proliferation in vitro. We have extended the system by preparing mouse T  cell 
lines and T  cell hybridomas that are specific for rabbit Ig, and by looking at the 
responses of B cells as well as T  cells in the presence of rabbit anti-IgM and anti- 
IgD. We show here th~it small, resting B cells can efficiently present either anti- 
IgM or anti-IgD to our T  Cell lines.  Efficient presentation depends upon mIg 
interaction and results in a B Cell as well as T  cell response. T  cell proliferation 
or lymphokine release, and polyclonal B cell responses occur with concentrations 
of anti-Ig that are several orders of magnitude lower (1-10 ng/ml) than those 
required  to  activate  B  cells  in  the  absence  of T  cells,  or  to  induce  B  cell 
responsiveness  to  stable,  antigen-nonspecific helper  factors  (>5  ~g/ml)  (28). 
Consequently, this polyclonal model system also requires helper T  cell functions 
that  cannot  be  replaced  by  such  factors,  and  so  more closely resembles  the 
antibody response  to  low  concentrations of a  protein  antigen.  Also,  like  the 
antibody  response  to  low  concentrations  of protein  antigens,  the  polyclonal 
responses  described  here  require  linked  recognition,  and  are  largely  MHC- 
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Materials and  Methods 
Mice.  Mice were obtained from The Jackson Laboratory, Bar Harbor, ME, and used 
at 8-32 wk of age. 
Antibodies and Cell Lines.  Class-specific, affinity-purified rabbit antibodies to mouse 
IgM and IgD were prepared as described previously, and their specificity was checked by 
immunoprecipitation of radiolabeled mouse spleen cell plasma membranes (18).  F(ab')~ 
rabbit  antiphenylarsonate  antibody (anti-Ars)  was prepared  similarly.  Affinity-purified 
goat anti-IgM was a gift of Fred Finkelman (Uniformed Services University of the Health 
Sciences, Bethesda, MD), and was lightly arsanilated on amino groups with an imidoester 
analog of tyrosine azophenylarsonate, as described (29).  Normal rabbit globulin (NRG) 
was prepared from pooled normal or preimmune serum on protein A-Sepharose (PAS), 
or was purchased from Sigma Chemical Company (St.  Louis, MO). F(ab')2 fragments of 
NRG or specific antibodies were prepared by digestion with pepsin, and residual, intact 
IgG was removed on PAS (Sigma Chemical Co.). 
The M12.4.1  B cell lymphoma of BALB/c origin (30) was a gift of Laurie Glimcher 
(Harvard School of Public  Health,  Boston,  MA).  The  8-azaguanine-resistant BW5147 
AKR  thymoma  cell  line,  also  from  Glimcher,  was  a  gift  of  Paula  Hochman  (Tufts 
University Medical School, Boston, MA). 
T Cell Hybridomas.  Antigen-specific T cell hybridomas were established by the method 
of Kappler et al. (31), by fusion of BW5147 with rabbit globulin-specific T  cells. The T 
cells were either from an established cell line or were T  cell blasts obtained from draining 
lymph nodes of (C3H/HeJ x  DBA/2J)F~ (C3D2) mice that had been primed with 100 gg 
of F(ab')2 of normal rabbit IgG in the tail and footpads, and boosted in vitro with F(ab')2 
NRG (100 #g/ml) and irradiated spleen cells.  2.5  ×  107 T  cell blasts or 107 cells of a T~ 
cell line were fused to equal numbers of BW5147 cells,  and distributed into 400 micro- 
culture wells in 0.1 ml HAT (hypoxanthine, aminopterin, thymidine) medium, which was 
changed every 5 d. Hybrid growth was detectable at 2-4 wk. Growing wells were expanded 
to  1-ml cultures,  then  tested  for antigen-induced  interleukin  2  (IL-2) release, and the 
ability to induce  B cell proliferation and Ig secretion in the presence of F(ab')~ rabbit 
anti-Ig. Positive cultures were cloned and subcloned as soon as possible at 0.1  input cells/' 
well.  The hybridomas occasionally lost activity, and so required  periodic recloning 'or 
recovery from liquid nitrogen storage. 
T Cell Lines.  Antigen-specific T  cell lines were established from lymph node cells of 
C3D2  mice that  had  been  primed  with  F(ab')~ NRG  in  vivo and  boosted  in  vitro as 
described above. After the second stimulation with antigen and irradiated spleen cells, 
limiting dilution  lines,  at  100  input  cells/well,  were  established  in  vitro according  to 
Kimoto and Fathman (32), using an ammonium sulfate fraction (40-80% saturation) of 
supernatant from concanavalin A  (Con A)-treated rat spleen cells as a  source of IL-2. 
Growing microwells were transferred to  1-ml cultures and tested for ability to support 
F(ab')2 anti-Ig-dependent B cell responses. Active lines were transferred to upright culture 
flasks, and were maintained by restimulation of 4 ×  105 cells every 2-3 wk with 2 ×  107 
irradiated spleen cells (done in 8 ml of medium containing 100 #g/ml F(ab')~ NRG, and 
IL-2 from rat spleen Con A  supernatant).  Although  most of the limiting dilution lines 
have the properties of clones (stable phenotype, restriction to one of the two maternal 
MHC haplotypes), they have not been subcloned at high plating efficiency, and are not 
certain to be clones.  Unlike the bulk cultures,  which become overgrown with antigen- 
independent,  autoreactive T  cells in  ~8  wk,  the  limiting dilution  lines have remained 
antigen-dependent for 1 yr in culture. They have been frozen and recovered from liquid 
nitrogen  storage.  Most  of the  lines  have remained  dependent  on  IL-2 in  addition  to 
antigen and irradiated spleen cells, but~the line shown in Table II was weaned from IL-2, 
after which it showed a mu~:h better proliferative response to antigen. 
Cell Preparation.  Spleen cell suspensions were treated with an anti-Thy-l.2 (HO-13- 
14) monoclonal antibody (mAb) plus agarose-absorbed guinea pig complement (C). Small 
B cells were then isolated by counterflow centrifugal elutriation (model J-6B; Beckman 
Instruments,  Palo Alto,  CA) (33).  Briefly,  1-5  ×  108 cells in  8  ml culture  medium or 
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nuclease, loaded into the elutriation chamber with a starting countercurrent flow rate of 
13.5 ml/rnin, and spun at 4 °C at a constant speed of 3,200 rpm. A small-cell fraction with 
very few contaminating large cells was eluted, typically at  14-17  ml/min, although the 
exact flow rate depended on the medium in which the cells were suspended. The fractions 
for each experiment were size-analyzed using a Coulter Channelyzer (Coulter Electronics, 
Inc., Hialeah, FL). The small-cell fraction, 5-20% of the input cell number, gave a nearly 
symmetrical peak, with a mean cell volume of 120 t~m  s. The small-cell fraction was also 
depleted of accessory cells, as shown by the ablation of Con A response in the small-cell 
fraction of untreated spleen cells. When indicated, cells were irradiated with a  cesium 
source. 
Cell Cultures.  Unless otherwise noted, 10  s B cells and 3 x  104 T  cells were cultured 
in flat-bottomed 96-well plates in 0.2 ml RPMI 1640 (Gibco Laboratories, Grand Island, 
NY) containing 5 x  10  -s M 2-mercaptoethanol, 100 U/ml penicillin, 100 ~g/ml strepto- 
mycin, 2  mM  glutamine, and  10%  heat-inactivated FBS  (2G034;  M.A.  Bioproducts, 
Walkersville,  MD). Some cultures received mouse spleen Con A supernatant (50% solu- 
tion) (34) as a source of T cell-derived helper factors, instead of T cells. 
Assays.  DNA synthesis was estimated by incorporation of [SH]thymidine (1 #Ci/well, 
2  Ci/mmole; New England Nuclear,  Boston, MA) during a  4  h  pulse on day 3.  The 
polyclonal assay for Ig-secreting cells as direct reverse plaques, using sheep red cells coated 
with anti-mouse Fab, has been described (35).  The H-2 type of the secreting cells was 
determined by incubating cultured cells with anti-H-2K  k mAb (clone 11-4.1;  American 
Type Culture Collection, Rockville,  MD) for 30  min at 4°C, and then with absorbed 
rabbit C at 37°C for 45 min. IL-2 production by the T cell hybridomas was measured by 
proliferation of an I L-2-dependent T cell line as described (19). Our unit of I L-2 has half- 
maximal activity at a dilution of 1:8-1:16 in the IL-2 assay. 
Results 
Rabbit Ig-specific T Cell Hybridomas  and T Cell Lines.  T  cell lines were derived 
from lymph node cells of C3D2 mice primed with the F(ab')~ fragment of NRG, 
and stimulated in vitro with antigen and irradiated syngeneic spleen cells. We 
obtained limiting dilution lines using IL-2, and selected them for their ability to 
stimulate B  cell proliferation and  Ig secretion,  dependent on the presence  of 
rabbit anti-Ig. We maintained them by periodic restimulation with antigen, spleen 
cells, and IL-2. T  cell hybridomas were generated by fusing primed C3D2 lymph 
node cells, enriched in vitro for specific T  helper cells, or long-term specific T 
cell  lines  to  BW  5147.  The  T  cell  hybridomas  were  screened  for  (a)  IL-2 
production, (b) ability to induce B cell proliferation, and (c) ability to induce B 
cell Ig secretion. We considered it necessary to screen in all three assays, because 
it was not clear whether all activities were related to each other. We found that, 
from four separate fusions, 124 out of 1,000 wells positive for cell growth were 
active in at least one of the assays. They were cloned as soon as possible,  and 
selected clones with helper activity were subcloned. We obtained ~20 stable T 
cell hybridoma clones. All clones with helper activity for B cell proliferation were 
also  IL-2  producers  and  vice versa,  but  only ~40%  of these  also  induced  Ig 
secretion. So far, we have found no hybridoma clones that have completely lost 
their ability to secrete IL-2 but are still able to deliver help for B cell proliferation. 
Functional Characteristics  of the Rabbit Ig-specific T Cell Hybridomas  and T  Cell 
Lines.  The following characteristics of the T  cell hybridomas and T  cell lines 
are representative of the  12  independently established T  cell hybridomas and 
five T  cell lines that we have studied more carefully. Table I shows the require- 
ments for IL-2 release by the T  cell hybridoma 2R50.20.  2R50.20 produces no TONY  AND  PARKER 
TABLE  I 
Functional Characteristics of a Rabbit Globulin-specific  T Cell Hybridoraa 
227 
T-depleted spleen  Additions 
cells 
IL-2 release*  B cell prolifera-  2R50.20 stimula- 
tion*  tion of:  0 
BW  2R50.20  BW 5147  2R50.20  5147 
B cell Ig  B cell re- 
secretion 
cover)  t 
(secret-  (× 10" 
ing 
cells/cul-  cells/cul- 
ture)  ture) 
C3D2 (H-2 K  × H-2  a) 
B10.D2 (H-2 d) 
B10.BR (H-2 k) 
#g/ml  cpm  cpm 
Nil  303  380  2,890  1,450  540  5.2 
F(ab')2a#  1  ND  I  ND  30,285  6,308  ND  ND 
F(ab')2a#  5  4,531  303  243,395  16,191  3,700  38.6 
F(ab')2a~  10  2,371  412  119,558  8,064  21,700  24.5 
LPS  58,7001  23.3 t 
Nil  328  302  1,881  1,472  230  5.8 
F(ab')2a#  1  ND  ND  92,368  3,414  58,400  31.6 
F(ab')2a#  5  8,345  292  158,412  8,431  ND  ND 
F(ab')~a~  2  6,981  358  198,666  1,138  55,200  25.5 
F(ab')~a~ 10  7,204  328  108,431  1,699  45,400  29.5 
LPS  96,168  ~ 
Nil  287  345  1,002  ND  30  4.3 
F(ab')~a#  1  292  361  2,992  ND  0  3.1 
F(ab')~a#  5  332  392  9,321  ND  ND  ND 
F(ab')~a~  2  392  299  989  ND  ND  ND 
F(ab')~a~ 10  301  336  1,298  ND  0  4.5 
LPS  89,4991 
2R50.20,  the  T  cell hybridoma, is compared with  BW  5147,  the  fusion  partner.  3  ×  104  T 
hybridoma cells (2R50.20),  or fusion partner tumor cells (BW 5147),  were given 3,000 rad and 
incubated with 105 T-depleted spleen cells and various additions. 
* After 24 h, culture supernatants were tested for IL-2 activity. 
at Cultures were pulsed with [SH]thymidine at 68-72 h of culture. 
| Cell recoveries and numbers of Ig-secreting cells were determined on day 4. 
I ND, not done. 
i 105 T-depleted spleen cells were cultured with 50 t~g/ml LPS without T cells. 
IL-2 constitutively and has no autoreactivity. It secretes IL-2 when it is stimulated 
with  rabbit  F(ab')2  anti-Ig  [RF(ab')2  anti-IgM  or  RF(ab')2  anti-IgD]  on  the 
appropriate antigen-presenting  cell.  2R50.20,  derived from H-2 k x  H-2  d lymph 
node cells, recognizes only cells bearing the H-2  d haplotype. The fusion partner, 
BW 5147, releases  no IL-2 under  these conditions.  The  T  cell hybridomas can 
also deliver help to B cells, measured by >  10-fold enhancement of DNA synthesis 
in syngeneic B  cells (B cell proliferation).  The  response with the fusion partner, 
BW  5147,  shows  the  intrinsic  stimulatory  activity  of the  anti-Ig  preparations 
used  (Table  I).  In  addition,  2R50.20  induces  actual  B  cell  proliferation,  as 
measured by cell recovery after 4  d  of culture,  and,  finally, induces high rate Ig 
secretion  in  syngeneic  B  cells  even  with  less  than  mitogenic  doses  of anti-Ig 
(Table  I). 
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TABLE  II 
T Cell Line Is Specific  for Rabbit Globulin Rather Than Activation 
Antigens on B Cells 
Additions to culture* 
None 
Rabbit F(ab')~ anti-IgM 
T cell proliferation 
#g/ml  cpm 
110 
0.001  88O 
0.01  9,930 
0.1  29,180 
1.0  18,360 
10.0  14,110 
Goat anti-IgM  0.001  80 
0.01  90 
0.1  170 
1.0  200 
10.0  300 
Rabbit F(ab')~ NRG  190  12,007 
* Cell cultures contained 10  ~  irradiated (1,000 rad) syngeneic  T-depleted 
spleen cells  and 3 × 104 CDC35 T cells. 
time (CDC  35), after being "weaned" of IL-2, for proliferation in response to 
antigen. This line requires only ng/ml concentrations of anti-Ig for activation. 
The specificity for rabbit Ig determinants is shown by the failure of goat anti- 
IgM antibodies, at submitogenic as well as mitogenic concentrations, to stimulate 
the T  cell.  This rules out the possibility that the T  cell  line is reactive to an 
activation antigen expressed on B cells in response to cross-linking mIg with anti- 
IgM antibodies. The same is true for the T  cell hybridoma 2R50.20, as shown 
by assaying T  cell help induction for B cell proliferation (Fig. 1). Moreover, Fig. 
1 a shows that a rabbit antibody with a specificity not directed to mIg [RF(ab')~ 
anti-Ars] is, even at concentrations 100  times higher than optimal for anti-Ig, 
unable to activate the T  cell hybridoma. However, by using arsanilated goat anti- 
Ig plus RF(ab')2 anti-Ars, the rabbit anti-Ars is bound to cross-linked mIg in a 
hapten sandwich. Under these conditions, rabbit  Ig determinants can be pre- 
sented, and the T  cell hybridoma is able to deliver help to the B lymphocytes. It 
is important to note that the response does not require mitogenic concentrations 
of goat anti-Ig antibodies. Mixing unarsanilated goat anti-Ig and RF(ab')2 anti- 
Ars does not induce a response (Fig' 1 b). This indicates that B cell proliferation 
in  response  to  the  T  cell  hybridoma  depends  on  recognition  of rabbit  Ig 
determinants on the B cell. 
Antigen Presentation  by Small,  Resting B  Lymphocytes.  To determine whether 
these  responses  required  either  conventional  accessory  cells  or  activated  B 
lymphocytes in the starting T-depleted spleen cell population, we subjected the 
cells to counterflow elutriation centrifugation. This procedure not only gives us 
small, resting B lymphocytes, but also depletes the B cells of accessory cells. We 
found the  accessory  cell  depletion  to  be  as  good  as  fractionation by  plastic 
adherence and two passes over Sephadex G- 10, as it abrogates the Con A response 
of the fractionated spleen cells before treatment with anti-Thy-1. Fig. 2 shows A. 
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FIGURE  1.  Induction  of help  for  B  cell  proliferation  depends  upon  attachment  of rabbit 
B  cell.  10  T-depleted  spleen cells were cultured with (solid  globulin to receptor  Ig on  the  5 
bars)  or  without  (open  bars)  3  x  l0  t  irradiated  T  hybridoma  cells  (2R50.20),  and  [SH]- 
thymidine  incorporation  was measured  at  72  h.  T  cells cause  a  large  enhancement  of the 
proliferative response to rabbit F(ab')~ anti-IgM [RF(ab')~a#], but not to goat anti-IgM (Ga#) 
or arsanilated Ga# (are Ga.).  Rabbit antiphenylarsonate antibody [RF(ab')~aars], which does 
not bind to the B cell, does not stimulate a response unless added together with ars Ga#, which 
allows it to attach to the B cell in a hapten sandwich. The experiment in B shows that the Ga# 
must be arsanilated in order to allow T  cell-dependent stimulation with RF(ab ')iaars. 230  ANTI-Ig  AS  A  MODEL  FOR  T  CELL-B  CELL  COLLABORATION 
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FIGURE 2.  Rabbit anti-Ig is presented at least 10,000-fold more efficiently than NRG by T- 
depleted  spleen  cells  or  small  B  cells.  10  s  small  DBA/2  B  cells  (open  symbols)  or  105 
unfractionated, T-depleted spleen cells (closed symbols) were cultured with 3 x  104 2R50.20 
hybridoma  cells and  indicated amounts  of F(ab')2 anti-lgD (A, A) or F(ab'),  NRG (r'l, m). 
Supernatants were assayed for IL-2 at 16 h. 
that small B lymphocytes depleted of accessory cells are fully capable of present- 
ing anti-Ig to an NRG-specific T  cell hybridoma, as measured by IL-2 release. 
The  small  cells are  as  effective as  unfractionated anti-Thy-1  plus  C-treated 
spleen cells, which includes accessory cells as well as large B cells (Fig. 2). 
Previous studies have shown that accessory cell-depleted B cell blasts (14, 27), 
or B tumor cells (36) present RF(ab')2 anti-Ig at much lower concentrations than 
RF(ab')2 NRG. Our experiments confirm the remarkable efficiency with which 
anti-Ig is presented by B cells (Fig.  2).  In addition, we show that a mIg- B cell 
tumor line, M12.4.1,  which cannot engage in mIg-mediated events, shows the 
same high concentration requirement for F(ab')~ anti-Ig as for F(ab')2 NRG (Fig. 
3).  This important control shows that the T  cell hybridoma cannot distinguish 
our anti-Ig from our NRG preparation (by allotype or variable region differences) 
when presented on a surface Ig- cell. However, unlike others (14), who found 
that antigen-presenting function was limited to B cell blasts, we find that small B 
cells  present  anti-Ig  very  efficiently, even  at  concentrations  far  below  that 
required to induce an increase in cell size in the absence of T  cells (18).  This 
discrepancy can now be explained by the finding that the antigen-presenting 
function of small, resting B cells is highly radiation-sensitive (37) for antigens the 
B cell takes up, presumably, via nonspecific binding. Using low concentrations 
of anti-Ig, which can bind and cross-link mIg of small B cells, we find the same 
result: the antigen-presenting capability of small B cells is lost rapidly at doses 
> 1,000 rad (Fig. 4). This radiation sensitivity is in contrast to all classical antigen- 
presenting  cells,  whose  antigen-presenting  function  is  radioresistant.  In  the 
experiment shown in Fig. 4, the antigen-presenting function of the unfraction- ~p 
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FIGURE 3.  The T cell hybridoma does not distinguish F(ab')~ anti-IgD (&) from F(ab')2 NRG 
(I) when presented on surface IgD- B lymphoma cells.  5 ×  104 M 12.4.1  cells were cultured 
with 3 ×  104 2R50.20 cells, and IL-2 was measured after 16 h. 
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FIGURE  4.  Radiosensitivity  of antigen  presentation.  ] 05 small B  cells (solid lines) or  ] 05 T- 
depleted spleen cells (broken line) were irradiated with the indicated doses and cultured with 
3 ×  104 2R50.20 cells and F(ab')~ anti-lgD (*, I,  10 #g/ml; A, 1 #g/ml; O, 0.1 #g/ml). IL-2 
accumulation was measured at 16 h. 
ated, T-depleted spleen cells is,  likewise, shown to be radiosensitive.  In other 
experiments (not shown), we have found a radioresistant cell in unfractionated 
spleen which presents anti-Ig efficiently and may be a  B  cell blast  which was 232  ANTI-Ig AS  A  MODEL  FOR  T  CELL-B  CELL  COLLABORATION 
activated  in  vivo before  the  spleen  was removed.  Activated  B  cells are  radiore- 
sistant and are present  in variable numbers  among  normal spleen cells (14). 
Polyclonal Activation of Sraall, Resting B Lymphocytes.  Small, resting B  lympho- 
cytes differ from larger, in vivo preactivated  B  lymphocytes in their requirement 
for activation  (38,  39).  Therefore,  we wanted  to know  whether  accessory  cell- 
depleted, small B cells (which, as shown above, can activate the T  cell hybridoma) 
are also able to receive T  cell  help.  Fig.  5  shows  that  2R50.20  can also deliver 
help to small, resting  B  cells over a  range  of concentrations  of anti-IgM  as well 
as anti-IgD.  The  response is proportional  to the B cell concentration  per culture 
and  does  not  disappear  at low cell concentrations,  as does  the  response  to anti- 
Ig  and  helper  factors.  In  addition,  there  is  no  significant  difference  between 
unfractionated  B  cells,  which  include  large  B  cells  and  accessory  cells,  and 
accessory  cell-depleted,  small,  resting  B  lymphocytes,  even  at  very  low  cell 
concentrations. 
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Small B cells respond as well as unfractionated T-depleted spleen cells to anti-Ig 
and a  rabbit globulin-specific T  cell  hybridoma, even at low cell concentrations.  Cultures 
contained either 5 x  10" irradiated 2R50.20 cells or helper factors (50% mouse splenic Con 
A supernatant) and F(ab')~ anti-IgD (t,  10 .g/ml; A, 2 #g/ml; It, 0.4 #g/ml) or F(ab'), anti- 
lgM (@, 5 #g/ml; A, 1 .g/ml; It, 0.2 #g/ml). [SH]Thymidine incorporation was measured at 
72 h. Cultures which received F(ab'), anti-IgM (0.2 #g/ml) or F(ab'), anti-lgD (10 #g/ml, 2 
#g/ml, 0.4 ~tg/ml) with helper factors showed only background responses. Subtracted back- 
ground  responses  without  anti-Ig were  for  small  B cells  (101,  162,  238,  774  cpm) and 
unfractionated, T-depleted spleen cells (104,  189, 396,  1541 cpm) for 3 x  l0 s, 104, 3'~X 104, 
and 105 cells/well, respectively. TONY  AND  PARKER  233 
Nature of T Cell Help.  As shown above, the help mediated by T  cells in these 
cultures is  MHC-restricted, since T  cell recognition of antigen on  the B  cell 
surface is MHC-restricted. However, the question remained whether this MHC 
restriction applies only to the requirements for T  cell activation, or if T  cells, 
even after activation by an appropriate antigen-presenting cell, would help only 
B cells bearing appropriate MHC antigens. We tested this possibility in experi- 
ments where small B lymphocytes of appropriate, and different MHC haplotype 
were mixed and cultured together with anti-Ig and a T  cell line. At the end of 
the  culture,  we  measured  the  T  cell  help  received  by  small  B  cells  of the 
inappropriate MHC haplotype by treating the culture with anti-H-2 antibodies 
(to the appropriate H-2 haplotype) and C, immediately before the assay for Ig- 
secreting cells. 
Table III shows the result of such an experiment. The T  cell line, CDB41, 
which is specific for rabbit  Ig on H-2 k B lymphocytes, cannot be activated by 
anti-Ig on small H-2  b B cells, but these B cells can be activated by high concen- 
trations of anti-IgM and lymphokines. As expected, H-2  b Ig-secreting cells cannot 
be destroyed by treatment with anti-H-2  k and C before assay. On the other hand, 
this T  cell line, derived from a C3D2Ft  (H-2 k ×  H-2  a) mouse, can be activated, 
and can deliver help  to  small  C3D2  B  cells.  The  Ig-secreting cells from this 
response, as well as the response to lymphokines plus high concentrations of anti- 
IgM, can be abolished by treatment with anti-H-2 k plus C. When the two B cell 
populations  were mixed and activated with T  cells and low concentrations of 
anti-IgM or anti-IgD, the Ig-secreting cells present at the end of culture were all 
derived from C3D2  B  cells, as shown by their sensitivity to anti-H-2  k plus C. 
That is, the response is strictly MHC-restricted in the effector phase, even when 
B cells with the inappropriate MHC outnumber the responding B cells by 7 to 1 
(Table III, Exp. 2). 
However, at the higher concentrations of anti-IgM or anti-IgD, we see a small 
but significant deviation from MHC-restriction in the response. This deviation 
implies that MHC-restricted recognition of antigen on the B cell surface may not 
be an essential part of the machinery of delivery of help, although the presenting 
B cells are preferential recipients of help, particularly at low antigen concentra- 
tion. 
In  any  event,  it  is  clear  that  the  helper  T  cells  do  more  to  the antigen- 
presenting B cells than produce, locally, the same set of stable, MHC-unrestricted 
factors that have been shown to support the proliferative and secretory response  s 
that isolated B cells show to mitogenic concentrations of anti-Ig, since the T  cells 
produce B cell secretory responses under conditions of anti-Ig activation that are 
not sufficient to induce a response with exogenous helper factors alone. These 
conditions include low concentrations of F(ab')2 anti-IgM (Fig.  5),  F(ab')2 anti- 
IgD in soluble form at any concentration (Fig.  5) (15,  18),  and intact anti-Ig 
(Table III, Exp.  1), which we have shown blocks B cell activation even in the 
presence of helper factors by cross-linking Ig to the Fc receptor for IgG (18, 34). 
Role  of mlg.  This  leads  to  the  question  of what  role  mIg plays  in  B  cell 
activation,  where  these  different types of T  cell  help  are  required.  Fig.  6a 
directly compares the amounts of anti-Ig required to induce a  B cell response 
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TABLE  III 
MHC Restriction of T Cell Help 
Additions to culture  Ig-secreting cells after treat- 
ment with: 
Responding, small, T- 
depleted spleen cells  T  cell help  Anti-lg  Nil  C only  Anti'H2k  plus C 
Experiment 1 
5 x  104 B10 (H-2  b) 
5 x  104 C3D2 (H-2  k 
x  H-2  a) 
5X 104B10plus5x 
104 C3D2 
Experiment 2 
#glint 
Helper factors  F(ab')2 anti-lgM  10.0  15,900  22,800  11,800 
T  cells  F(ab')2 anti-lgM  0.1  40  --  -- 
Helper factors  F(ab')2 anti-lgM  10.0  24,400  23,000  10 
T  cells  F(ab')2 anti-IgM  0.1  25,900  25,900  <10 
Helper factors  F(ab')2 anti-lgM  10.0  27,300  44,900  18,400 
T  cells  None  700  --  -- 
T  cells  F(ab')2 anti-lgM  0.01  3,200  970  <10 
0.1  19,300  18,900  <10 
1.0  37,700  32,700  3,500 
10.0  7,800  7,700  1,600 
T  cells  F(ab')~ anti-lgD  0.01  3,800  1,100  10 
0.1  14,300  23,100  180 
1.0  29,200  30,200  2,900 
10.0  32,400  48,400  6,460 
T  cells  Intact anti-IgM  0.01  11,800 
10.0  7,520 
Intact anti-IgD  0.01  3,100 
10.0  22,380 
B 
D 
m 
m 
8 x  104 C3D2 plus 8  Helper factors  F(ab')2 anti-IgM  10.0  59,400  48,400  23,200 
x  104 B10  T  cells  F(ab')2 anti-IgD  0.1  17,600  13,300  50 
4 x  104 C3D2 plus 3  T  cells  F(ab')2 anti-lgD  0.1  17,300  16,100  90 
x  10 5 BIO 
Small B cells were cultured 4 d  with 3 x  104 T  cells (line CDB 41) or helper factors (50%  mouse 
splenic Con  A  supernatant).  After 4  d,  the H-2 type of the  Ig-secreting cells was  determined  by 
treatment with anti-H-2K  k plus C before the reverse plaque assay. 
kines. The anti-Ig dose response for B cell differentiation  is reported  to follow 
the ability of anti-IgM to induce G0-G1  transition (>1  #g/ml) (16-18),  if T  cell 
help  is  provided  in  the  form  of lymphokines.  However,  when  T  cell  help  is 
provided by MHC-restricted  T  helper cells,  the anti-Ig dose response seems  to 
be independent of direct  anti-Ig effects,  and resembles  only the dose response 
for T  cell activation (Table II).  For this cell line (CDC35),  even concentratiorjs 
of ~ 1 ng/ml antMg induce a B cell response.  Consequently, if an mlg-mediated 
signal is required for the response that is also dependent on MHC-restricted  T 
helper cells, the strength of the signal appears to be relatively minimal; concen- TONY  AND  PARKER  235 
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FIGURE 6.  A globulin-specific  T cell line (3 × 104 CDC35 cells) induces a secretory response 
from 105 small B cells at 10,000-fold lower concentrations of anti-Ig than that required with 
helper factors. (B) Rabbit F(ab')~ anti-Ars, which does not bind specifically  to the B cell, will 
also induce a response with T cells present, but at much higher concentrations (O). However, 
ng/ml quantities of F(ab')s anti-Ars are adequate if linked to the B cell surface by a hapten 
sandwich with arsanilated goat anti-IgM at 1 ng/ml (<>) or 10 ng/ml (12]). 10 ng/ml goat anti- 
IgM which was not arsanilated (V) failed to enhance the response to F(ab')s anti-Ars. 
trations  10,000-fold  lower  than  those  inducing  G0-G1  transition  seem  to  be 
sufficient (Fig. 6 a). Therefore, we wanted to know if a rabbit antibody that does 
not bind specifically to mlg can induce a  response in small B cells as well. Fig. 
6b shows that such an antibody (i.e., RF(ab')2 anti-Ars) can indeed induce a  T 
cell-dependent B cell response.  Because F(ab')~ anti-Ars cannot bind mlg, it is 
not, as shown above, presented by the B cells as efficiently as anti-Ig; response 
requires  about  four  orders  of magnitude  more  antibody (Fig.  6 b).  Giving a 
putative mlg-mediated signal with very low concentrations of goat anti-Ig anti- 
bodies does not alter the response to rabbit anti-Ars. However, if the goat anti- 
Ig antibody is arsanilated, then rabbit anti-Ars can bind to it, and thus, indirectly, 
to  mlg.  The  dose  response  then  shifts  to  concentrations  of rabbit  anti-Ars 
comparable to the necessary concentrations of rabbit anti-Ig. This experiment, 
like the experiment shown in Fig. 1, is the polyclonal analog of linked recognition. 
It demonstrates the important role of mlg for antigen presentation by B  cells. 
However, a  mlg-transduced B cell signal, comparable to the one crucial for the 
response of small B cells to stable lymphokines, is not required if T  cell help is 
provided by MHC-restricted helper cells, It remains to be determined whether 
mlg  plays  more  than  a  passive,  antigen-focusing  role  in  enhancing  antigen 
presentation in T-B collaboration. 
Discussion 
Based on the experiments described above, we conclude that small B cells are 
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lines and hybridomas. MHC-restricted recognition of rabbit globulin on the small 
B cell surface results both in T  cell activation and a  vigorous polyclonal B cell 
response. Antigen presentation and the ensuing B cell response does not require 
the well-characterized blastogenic response to anti-Ig, since the concentrations 
of anti-Ig required with some of the T  cell lines (Fig. 6) are  1,000-fold lower 
than the concentrations required to induce blast transformation (18) or increases 
in membrane Ia expression (40), DNA synthesis (41), or responsiveness to stable, 
antigen-nonspecific helper factors (28). 
Efficient presentation  of rabbit  anti-Ig by  small  B  cells is  mediated by  the 
endogenous mIg on  the  B  cell  surface  (Figs.  1-3,  and  6).  If one  makes  the 
reasonable assumption that antigens would be presented with comparable effi- 
ciency  by  antigen-specific  B  cells  (42),  then  the  experiments  reported  here 
provide a  new and useful polyclonal model for mIg-mediated, MHC-restricted 
T  cell help in the antibody response to low concentrations of protein antigens. 
According to the clonal selection theory, the interaction of antigen with mIg 
on the  B  cell  surface  enables  the  B  cell  to respond,  and  so accounts for  the 
specificity  of the  antibody  response.  The  role  of mIg  in  directly  producing 
activating signals, or in acting as a passive, antigen-specific address for other B 
cell-activating signals, has been a subject of much debate. In the model presented 
here, the primary role of mIg is to enable the B cell to bind antigen and present 
it to the helper T  cell, especially when antigen is present at very low concentra- 
tion. A signalling role for cross-linked mIg does not appear to be essential in this 
system, since an unrelated rabbit antibody that does not bind mIg (anti-Ars) will 
nevertheless induce T  and B cell activation if present at much higher concentra- 
tion (Fig.  6).  This result confirms other experiments,  with antigen-specific T 
cells at  high antigen  concentration  (9,  10,  39),  alloreactive  T  cells (7,  8),  or 
apparently autoreactive T  cells (26, 43, and our unpublished results) that poly- 
clonally activate B cells in the absence of apparent mIg involvement. This is not 
to deny the wealth of evidence for positive and negative signals that are delivered 
through  mIg in  other  experimental  systems,  some  of which are  likely  to  be 
physiologically relevant.  Even in systems where  B  cells can be driven without 
mIg involvement, antigen or anti-Ig can enhance or suppress responses (8,  11, 
24, 43, 44). 
Although mIg signalling appears to be unnecessary for T  cell-dependent B 
cell  activation,  it  may  play  more  than  a  passive  (antigen  "focusing")  role  in 
binding antigen to the B cell surface. Antigen presentation requires a time- and 
energy-dependent  process  of  antigen  processing.  Two  laboratories  (45,  46) 
recently showed that antigen processing for protein antigens requires, and may 
be  limited  to,  denaturation  or  partial  proteolysis,  since  prefixed  cells  could 
present  partially  hydrolyzed  or  denatured  protein  antigens,  but  not  native 
globular proteins, to T  cell hybridomas like ours. Consequently, it is likely that 
our globulin-reactive T  cells also see processed antigen rather than native antigen 
bound to mIg. Thus, mIg may be functionally specialized to enable the B cell to 
efficiently process and present antigen to the helper T  cell, perhaps by aiding in 
antigen internalization (47).  This question can be approached by determining 
requirements for cross-linking, using monovalent antibodies, and by comparing TONY  AND  PARKER  237 
mIg with other B  cell surface molecules for the efficiency of presentation of 
attached rabbit antibodies. These experiments are in progress. 
In contrast to our findings, some experiments in other laboratories suggest 
that small, resting B cells are deficient in their ability to present alloantigens or 
protein antigens to T  cells, even when their radiosensitivity is taken into account 
(8,  37,  48).  It should be noted that the experiments reported here were per- 
formed with T  cell lines and hybridomas, which may have less stringent require- 
ments for activation  than  normal  or  in  vivo primed  T  cells.  For instance,  a 
requirement for MHC-appropriate accessory cells may reflect a requirement for 
an accessory cell function, e.g.,  production of IL-1  or some other factor, for 
activation of helper T  cells to a  stage where they can interact directly with an 
antigen-presenting small  B  cell.  Also,  our  limiting dilution  lines  and  cloned 
hybridomas, though induced and maintained by conventional procedures, were 
selected for their ability to induce B cell responses. If T  cell lines are heteroge- 
neous  in  their  requirements  for  accessory cells,  or  in  their  preferences for 
recognizing antigen on different kinds of antigen-presenting cells, then we may 
have selected those that are particularly adept at recognizing antigen presented 
on small B cells. 
Although much remains to be learned, our experiments also tell us something 
about the mechanisms by which T  cells help B cells when they recognize antigen 
on the B cell surface. At the very low concentrations of anti-Ig able to induce a 
B cell response in the presence of T  cells, the B cells are not responsive to stable, 
antigen-nonspecific helper factors of the kind found in the culture supernatants 
of Con A-activated spleen cells (Fig.  6).  Consequently, as stated above, the T 
cells must be providing helper functions in addition to the secretion of this kind 
of helper factor. One possibility is that this kind of T  cell help requires close cell 
contact mediated by specific recognition, by analogy with  target  cell lysis  by 
cytolytic T  cells.  In  a  mixture of target  cells and  "innocent bystander"  cells 
bearing inappropriate MHC alleles, cytolytic T  cells will kill their MHC-appro- 
priate targets and spare the bystanders. When we performed similar experiments 
with our helper T  cells, we found that the MHC-appropriate, antigen-presenting 
B  cell accounted for the majority of the  Ig secretory response.  That  is,  T-B 
collaboration appeared to be MHC-restricted in the effector phase, since, under 
some conditions, bystander B cells bearing inappropriate MHC alleles did not 
become secreting cells even when mixed in the same culture vessel with MHC- 
appropriate B cells that were responding optimally to activated helper T  cells 
(Table III). However, the MHC restriction was not absolute; the degree of the 
bystander  response  depended  on  the  particular  T  cell  line  and  the  antigen 
concentration. When we looked earlier in the sequence of B cell activation, at 
DNA synthesis in MHC-inappropriate bystanders (unpublished experiments), we 
found less MHC restriction, in agreement with others (I0), who detected DNA 
synthesis or blast transformation of MHC-inappropriate bystanders in polyclonal 
B cell responses induced by antigen-specific T  cells at high antigen concentra- 
tions.  We conclude that a  limiting helper T  cell function acts at short range, 
since the MHC-appropriate,  antigen-presenting B cell is helped preferentially, 
particularly when one measures high-rate Ig secretion, a late event in the B cell 
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the finding of MHC-restriction of T-B cell collaboration in vivo (2, 3). However, 
since MHC-inappropriate B cells, which cannot serve as antigen-presenting  cells 
(as determined by T  cell activation), can receive some help, it seems likely that 
the  molecular  machinery  of help  is  distinct  from  the  machinery  of specific 
recognition; i.e., that help does not require binding of B cell Ia plus antigen  to 
the T  cell receptor. Whether help is mediated by a labile, short-range factor or 
by cell contact remains to be determined. 
Summary 
Anti-Ig has been widely used as a model for antigen receptor-mediated B cell 
activation. B cells activated with mitogenic concentrations of anti-Ig (~ 10 #g/ml) 
become responsive to a set of T  cell-derived, antigen-nonspecific helper factors 
that enable the B cells to proliferate, and, in some cases, mature to Ig secretion. 
In the present experiments, we show that anti-Ig can also be used as a model for 
major  histocompatibility  complex  (MHC)-restricted,  antigen-specific  T-B  cell 
collaboration. We used murine helper T  cell lines and T  cell hybridomas specific 
for a  protein antigen,  the F(ab')~ fragment of normal rabbit IgG. Small B cells 
are very efficient at presenting rabbit anti-IgM or rabbit anti-IgD to these rabbit 
Ig-specific T  cell lines and  hybridomas, and  the responding (initially)  small  B 
cells, appear to be the only antigen-presenting  cells required.  Efficient presen- 
tation depends upon binding  of rabbit antibody to mlg on the B  cell surface. 
MHC-restricted  recognition  of rabbit  Ig  determinants  on  the  B  cell  surface 
results  in  a  polyclonal  B  cell response.  This response is qualitatively different 
from  the  well-studied  response  to  blastogenic  concentrations  of anti-Ig  plus 
stable,  T  cell-derived  helper  factors,  since  it  (a)  requires  1,000-fold  lower 
concentrations of anti-Ig,  (b) involves helper T  cell functions other than,  or in 
addition  to,  the  local  production  of the  same  stable  helper  factors,  and  (c) is 
largely MHC-restricted at the T-B cell level. 
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